Robert J.J. van Es

ORCID: 0000-0002-4246-5899
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Head and Neck Cancer Studies
  • Salivary Gland Tumors Diagnosis and Treatment
  • Head and Neck Surgical Oncology
  • Fibroblast Growth Factor Research
  • Ear and Head Tumors
  • Reconstructive Surgery and Microvascular Techniques
  • Kruppel-like factors research
  • Cancer Diagnosis and Treatment
  • Oral and Maxillofacial Pathology
  • Cancer-related gene regulation
  • RNA modifications and cancer
  • Reconstructive Facial Surgery Techniques
  • Lung Cancer Treatments and Mutations
  • Medical Imaging Techniques and Applications
  • Tumors and Oncological Cases
  • Facial Trauma and Fracture Management
  • Radiopharmaceutical Chemistry and Applications
  • Bone health and treatments
  • Cancer Genomics and Diagnostics
  • Bone Tumor Diagnosis and Treatments
  • Prostate Cancer Treatment and Research
  • Cleft Lip and Palate Research
  • Medical Imaging and Pathology Studies
  • Cancer-related Molecular Pathways
  • Oral health in cancer treatment

University Medical Center Utrecht
2016-2025

Cancer Genomics Centre
2017-2025

Heidelberg University
2015-2024

University Hospital Heidelberg
2015-2024

The Netherlands Cancer Institute
2012-2024

Medisch Centrum Haaglanden
2024

University Medical Center Groningen
2024

Utrecht University
1997-2020

Wilhelmina Children's Hospital
2019

Radboud University Nijmegen
2012-2018

BackgroundOrganoids are in vitro three-dimensional structures that can be grown from patient tissue. Head and neck cancer (HNC) is a collective term used for multiple tumor types including squamous cell carcinomas salivary gland adenocarcinomas.MethodsOrganoids were established HNC tissue characterized using immunohistochemistry DNA sequencing. Organoids exposed to chemo- radiotherapy panel of targeted agents. Organoid response was correlated with clinical response. CRISPR-Cas9-based gene...

10.1016/j.medj.2023.04.003 article EN cc-by-nc-nd Med 2023-05-01

IntroductionThe presence of previously unnoticed bilateral macroscopic salivary gland locations in the human nasopharynx was suspected after visualization by positron emission tomography/computed tomography with prostate-specific membrane antigen ligands (PSMA PET/CT). We aimed to elucidate characteristics this unknown entity and its potential clinical implications for radiotherapy.Materials methodsThe configuration PSMA-positive area evaluated a retrospective cohort consecutively scanned...

10.1016/j.radonc.2020.09.034 article EN cc-by-nc-nd Radiotherapy and Oncology 2020-09-23

During posttreatment surveillance of head and neck cancer patients, imaging is insufficiently accurate for the early detection relapsing disease. Free circulating tumor DNA (ctDNA) may serve as a novel biomarker monitoring burden during these patients. In this exploratory study, we investigated whether low level ctDNA in plasma patients can be detected using Droplet Digital PCR (ddPCR).TP53 mutations were determined surgically resected primary samples from six with high stage (II-IV),...

10.1186/s12885-017-3424-0 article EN cc-by BMC Cancer 2017-06-19

Abstract Background Salivary duct carcinoma, an aggressive subtype of salivary gland cancer, is mostly androgen receptor‐positive. Only limited data are available on deprivation therapy (ADT). Methods Patients with advanced receptor‐positive carcinoma treated first‐line ADT were retrospectively evaluated for clinical benefit (ie, partial response [PR] and stable disease, progression‐free survival [PFS] overall [OS]). The OS was compared patients who received best supportive care. Results...

10.1002/hed.25035 article EN cc-by-nc-nd Head & Neck 2017-12-22

Salivary duct carcinoma (SDC) is a subtype of salivary gland cancer with dismal prognosis and need for better prognostication novel treatments. The aim this national cohort study was to investigate clinical outcome, prognostic factors, androgen receptor (AR) human epidermal growth factor 2 (HER2) expression. SDC patients diagnosed between 1990 2014 were identified by the Nationwide Network Registry Histo- Cytopathology in Netherlands (PALGA). Subsequently, medical records evaluated...

10.1002/ijc.31353 article EN cc-by-nc-nd International Journal of Cancer 2018-03-01

FGFR1 is a promising therapeutic target in multiple types of solid tumors, including head and neck squamous cell carcinoma (HNSCC). FGFR inhibitors have shown great value preclinical models. However, resistance remains major setback. In this study, we investigated the prognostic expression HNSCC, relevance targeting with AZD4547, potential resistant mechanisms.IHC FISH were applied on tissue microarrays to investigate protein gene copy numbers 452 HNSCCs. The sensitivity HNSCC lines either...

10.1158/1078-0432.ccr-15-1874 article EN Clinical Cancer Research 2016-03-03

Current assessment of lymph node metastasis in patients with head and neck squamous cell carcinoma is not accurate enough to prevent overtreatment. The aim this study was validation a gene expression signature for distinguishing metastasizing (N+) from nonmetastasizing (N0) the oral cavity (OSCC) oropharynx (OPSCC) large multicenter cohort, using diagnostic DNA microarray Clinical Laboratory Improvement Amendments/International Organization Standardization-approved laboratory.A multigene...

10.1200/jco.2011.40.4509 article EN Journal of Clinical Oncology 2012-10-09

Background and Objectives Evaluation of mandibular reconstructions with free fibula flaps. Identification factors associated major recipient site complications, that is, necessitating surgical intervention under general anaesthesia. Methods Seventy‐nine were included. The following analyzed: fixation type, number osteotomies, defect (bilateral/unilateral), surgeon, sex, ASA classification, continuous smoking, pathological N‐stage, age, size, flap ischemic time, postoperative radiotherapy....

10.1002/jso.24976 article EN cc-by-nc-nd Journal of Surgical Oncology 2018-02-15

Fibula free flaps (FFF) are effective in accomplishing successful reconstruction for segmental defects of the mandible. Potential risk factors FFF complications have been described previous research, e.g. age, comorbidity and smoking. Low skeletal muscle mass (SMM) has shown to be an emerging predictive factor prognostic survival head neck cancer. This study aims identify value low SMM surgical related complications, postoperative patients who underwent mandibular with after oral cavity...

10.1016/j.oraloncology.2019.104530 article EN cc-by Oral Oncology 2019-12-24

10.1016/s0901-5027(97)80818-1 article EN International Journal of Oral and Maxillofacial Surgery 1997-06-01

Abstract Background There is an ongoing debate about the value of (neo‐)adjuvant chemotherapy in high‐ and intermediate‐grade osteosarcoma head neck. Methods All records patients older than 16 years diagnosed with neck Netherlands between 1993 2013 were reviewed. Results We identified a total 77 neck; 5‐year overall survival (OS) was 55%. In 50 surgically resected or younger 75 years, univariate multivariable analysis, adjusting for age resection margins, showed that who had not received...

10.1002/hed.24556 article EN cc-by-nc-nd Head & Neck 2016-08-10

Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis 9 AdCC was conducted to analyse visualization on PSMA PET/CT investigate expression primary, recurrent metastatic tissue using immunohistochemistry. Local occurred in six eight developed metastasis. All PET/CTs depicted PSMA-ligand...

10.1007/s00259-017-3737-x article EN cc-by European Journal of Nuclear Medicine and Molecular Imaging 2017-06-07

Complete resection of tongue cancer is necessary to achieve local control. Unfortunately, deep margins are frequently inadequate. To improve margin control, accurate knowledge tumour thickness pivotal. Magnetic resonance imaging (MRI) and intraoral ultrasound (ioUS) applied for staging. This study explores the accuracy these techniques estimate depth invasion.The data patients with a T1-2 that had been treated surgically between 2014 2018 were retrospectively analysed. Measurements taken by...

10.1016/j.oraloncology.2020.104895 article EN cc-by Oral Oncology 2020-07-09

Surgical removal of squamous cell carcinoma the tongue (SCCT) with tumour-free margin status (≥5 mm) is essential for loco-regional control. Inadequate margins (<5 often indicate adjuvant treatment, which results in increased morbidity. Ultrasound (US)-guided SCCT resection may be a useful technique to achieve more adequate compared conventional surgery. This study evaluates application and accuracy this technique.Forty patients were included consecutive US cohort. During surgery, surgeon...

10.1016/j.oraloncology.2022.106023 article EN cc-by Oral Oncology 2022-07-25

Abstract Current conventional treatment modalities in head and neck squamous cell carcinoma ( HNSCC ) are nonselective have shown to cause serious side effects. Unraveling the molecular profiles of cancer may enable promising clinical applications that pave road for personalized treatment. We examined copy number status 36 common oncogenes tumor suppressor genes a cohort 191 oropharyngeal carcinomas OPSCC 164 oral cavity OSCC using multiplex ligation probe amplification. Copy was correlated...

10.1002/cam4.499 article EN cc-by Cancer Medicine 2015-07-21
Coming Soon ...